D.E. Shaw & Co’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $22M | Buy |
|
|||||
|
2025
Q2 | $1.96M | Buy |
|
|||||
|
2025
Q1 | $1.3M | Sell |
|
|||||
|
2024
Q4 | $2.65M | Sell |
|
|||||
|
2024
Q3 | $4.94M | Buy |
|
|||||
|
2024
Q2 | $2.52M | Sell |
|
|||||
|
2024
Q1 | $3.03M | Buy |
|
|||||
|
2023
Q4 | $346K | Sell |
|
|||||
|
2023
Q3 | $1.08M | Sell |
|
|||||
|
2023
Q2 | $2.39M | Sell |
|
|||||
|
2023
Q1 | $4.98M | Sell |
|
|||||
|
2022
Q4 | $8.48M | Sell |
|
|||||
|
2022
Q3 | $13.4M | Buy |
|
|||||
|
2022
Q2 | $1.77M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $221K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $242K | Buy |
|
|||||
|
2018
Q3 | $526K | Buy |
|